Short Description

Oncomine Tumor mutation Burden (TMB) is performed using NGS methodology. Sample that have to be given is Tumor tissue in Paraffin embedded tissue blocks for this test. You can expect results in 2-3 weeks

PreTest Information

Oncomine Tumor mutation Burden (TMB) can be done with a Doctor’s prescription. Prescription is not applicable for surgery and pregnancy cases or people planing to travel abroad.

Detail Description

Oncomine Tumor Mutation Burden (TMB) Test - Cost, Symptoms, and Diagnosis in India

Oncomine Tumor Mutation Burden (TMB) test is a genetic test that helps in identifying the number of mutations present in the tumor DNA. It is a new biomarker that is used to predict the response of cancer patients to immunotherapy. The test is performed using a Next-Generation Sequencing (NGS) technology that allows the detection of mutations in multiple genes simultaneously. DNA Labs India provides Oncomine Tumor Mutation Burden (TMB) test at a cost of INR 42000.

What are the Symptoms of Tumor Mutation Burden?

Tumor Mutation Burden (TMB) is not a disease, but it is a measure of the number of mutations present in the tumor DNA. Therefore, there are no specific symptoms of TMB. However, high TMB levels have been associated with better response to immunotherapy in cancer patients.

How is Oncomine Tumor Mutation Burden Test Performed?

The Oncomine Tumor Mutation Burden (TMB) test is performed using a Next-Generation Sequencing (NGS) technology. The test requires a small sample of tumor tissue that is collected during biopsy or surgery. The tissue sample is sent to the laboratory for analysis. The DNA is extracted from the tumor tissue and is sequenced using NGS technology. The sequencing data is then analyzed to identify the number of mutations present in the tumor DNA. The results of the test are reported as the number of mutations per megabase of DNA.

What is the Cost of Oncomine Tumor Mutation Burden Test in India?

The cost of Oncomine Tumor Mutation Burden (TMB) test in India is INR 42000. DNA Labs India is one of the few laboratories in India that provides this test. The cost of the test may vary depending on the location and the laboratory where it is performed.

What are the Benefits of Oncomine Tumor Mutation Burden Test?

The Oncomine Tumor Mutation Burden (TMB) test provides several benefits, including:

• It helps in predicting the response of cancer patients to immunotherapy.
• It provides a more accurate assessment of the tumor's mutational burden than other biomarkers.
• It helps in identifying patients who are more likely to benefit from immunotherapy.
• It helps in selecting the most appropriate treatment for cancer patients.

Conclusion

The Oncomine Tumor Mutation Burden (TMB) test is a valuable tool for predicting the response of cancer patients to immunotherapy. It is a new biomarker that is gaining popularity among oncologists and researchers. DNA Labs India provides this test at a cost of INR 42000. If you are a cancer patient or have a family member who is suffering from cancer, it is recommended to discuss the benefits of this test with your oncologist.

By providing accurate results, this test can help in selecting the most appropriate treatment for cancer patients, which can improve their chances of survival and quality of life.

For more information about Oncomine Tumor Mutation Burden (TMB) test, you can visit the DNA Labs India website.